Peter Ueda

Assistant professor

About me


Current positions

  • Assistant professor, Karolinska Institutet
  • Physician, Department of Endocrinology, Karolinska University Hospital
  • Affiliated researcher, University of Tokyo

Education and previous positions

  • Docent in epidemiology, Karolinska Institutet, 2020
  • Intern physician (AT-läkare), Södersjukhuset & postdoc, Karolinska Institutet, 2017-2020
  • Post-doctoral researcher, Harvard University, 2014-2016
  • PhD, Karolinska Institutet, 2014
  • BSc, Stockholm School of Economics (Handelshögskolan), 2012
  • MD, Karolinska Institutet, 2012 

Research description


We address research questions of relevance to public health and clinical decision making, with a main clinical interest in internal medicine and endocrinology. We use methods for causal inference, simulations, and risk prediction modelling in observational and interventional study designs.

Main research areas include:

Safety and effectiveness of glucose-lowering drugs

We use nationwide data sources from three countries to emulate clinical trials in observational data (Björn Pasternak Group) Focus on treatment for type 2 diabetes, including SGLT2 inhibitors and GLP-1 receptor agonists. 

Cardiovascular risk prediction and pharmacological prevention of cardiovascular disease

We assess research questions related to primary and secondary prevention of cardiovascular disease, including validation of risk scores and assessment of guideline-recommended treatment algorithms. Focus on antiplatelet therapy and cholesterol-lowering drugs.

Emerging issues in sexual health and fertility 

Research program in collaboration with the University of Tokyo, with focus on young Japanese adults. Studies on the epidemiology of sexual activity and novel topics in sexual health research using data from national probability surveys. Some comments are presented here



Main supervisor for:

Co-supervisor for:


Research students


Our research is and has been funded by:

  • Swedish Heart-Lung Foundation
  • Swedish Diabetes Foundation
  • Swedish Society for Medical Research
  • Karolinska Institutet Foundations and Funds
  • Faculty-funded career position, Karolinska Institutet




Selected publications

Sakamoto H, Ishikane M, Ueda P. Seasonal Influenza Activity during the SARS-CoV-2 Outbreak in JapanJAMA 2020. 

Pasternak B, Wintzell V, Melbye M, Eliasson B, Svensson AM, Franzen S, Gubjörnsdottir S, Hveem K, Jonasson C, Svanström H, Ueda P Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort studyBMJ 2020

Allahyari A, Jernberg T, Hagström E, Leosdottir M, Lundman P, Ueda P. Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study Eur Heart J 2020

Pasternak B, Ueda P, Eliasson B, Svensson AM, Franzen S, Gubjörnsdottir S, Hveem K, Jonasson C, Wintzell V, Melbye M, Svanström H. Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study. BMJ 2019

Ueda P, Svanström H, Melbye M, Eliasson B, Svensson AM, Franzen S, Gubjörnsdottir S, Hveem K, Jonasson C, Pasternak B. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ 2018

Ueda P, Jernberg T, James S, Alfredsson J, Erlinge D, Omerovic E, Persson J, Ravn-Fischer A, Tornvall P, Svennblad B, Varenhorst C. External validation of the DAPT score in a nationwide populationJ Am Coll Cardiol 2018

Ueda P, Jernberg T, Varenhorst C. Reply: The DAPT score in Sweden. Successful validation, flawed interpretation. J Am Coll Cardiol 2019 

Svanström H, Ueda P, Melbye M, Eliasson B, Svensson AM, Franzen S, Gubjörnsdottir S, Hveem K, Jonasson C, Pasternak B. Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden. Lancet Diabetes & Endocrinology 2018

Howe BK*, Suharlim C*, Ueda P* (*Co-first authors), Howe D, Kawachi I, Rimm E. Gotta catch’em all! Pokémon GO and physical activity among young adults: difference in differences studyBMJ 2016  

Coverage in The Guardian and Forbes

Ueda P, Woodward M, Lu Y, Hajifathalian K, et al. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveysLancet Diabetes & Endocrinology 2017

Ueda P, Lung T, Clarke P, Danaei, G. Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis. British Journal of General Practice 2017

Coverage in The Guardian

Lu Y, Hajifathalian K, Ezzati M, Rimm E, Ueda P, Danaei G. Sick Population and Sick Subpopulations: Racial Disparities in Coronary Heart Disease Risk in the United StatesCirculation 2016

Hajifathalian K*, Ueda P* (*Co-first authors), Lu Y, Woodward M, et al. Globorisk: A novel risk score for predicting cardiovascular disease risk in national populations: a pooled analysis of prospective cohorts and health examination surveys. Lancet Diabetes & Endocrinology 2015

Ueda P, Rafatnia F, Bäärnhielm M, Fröbom R, Korzunowicz G, Lönnebro R, Eyles D, Olsson T, Alfredsson L. Neonatal vitamin D and risk of multiple sclerosis. Annals of Neurology 2014

Hult M*, Tornhammar P*, Ueda P* (*Co-first authors), Chima C, Edstedt-Bonamy A-K, Ozumba B, Norman M. Hypertension, Diabetes and Overweight: Looming Legacies of the Biafran FaminePLoS ONE 2010

Coverage in The New York Times

Loading bibliometrics...